CIK 0001211583 · Non-accelerated filer<br>Smaller reporting company
FENNEC PHARMACEUTICALS INC.
Sign in to watch- Ticker
- FENC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- operating
- Phone
- (919) 636-4530
- Business address
- PO BOX 13628, 68 TW ALEXANDER DRIVE, RESEARCH TRIANGLE PARK, NC, 27709
- Former names
- ADHEREX TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,310,718
- in 4 filings, $1.2M under 10b5-1 plans
Net −$1,310,718. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-16 | Haigh Adrian CHIEF OPERATING OFFICER | Sale 10b5-1 | −22,222 | $10.28 | $228K | 0 |
| 2024-04-16 | Haigh Adrian CHIEF OPERATING OFFICER | Option exercise · Common Shares 10b5-1 | −22,222 | $2.31 | $51K | 449,135 |
| 2024-04-15 | Haigh Adrian CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +22,222 | $2.31 | $51K | 22,222 |
| 2024-04-15 | Haigh Adrian CHIEF OPERATING OFFICER | Sale 10b5-1 | +22,222 | $2.31 | $51K | 22,222 |
| 2024-04-15 | Haigh Adrian CHIEF OPERATING OFFICER | Sale 10b5-1 | −22,222 | $10.30 | $229K | 22,222 |
| 2024-04-15 | Haigh Adrian CHIEF OPERATING OFFICER | Option exercise · Common Shares 10b5-1 | −22,222 | $2.31 | $51K | 471,357 |
| 2024-04-15 | RALLIS CHRIS A Director | Sale 10b5-1 | −800 | $10.45 | $8K | 44,449 |
| 2024-04-15 | RALLIS CHRIS A Director | Option exercise 10b5-1 | +1,389 | $10.45 | $15K | 45,838 |
| 2024-04-15 | RALLIS CHRIS A Director | Option exercise · Common Shares 10b5-1 | −1,389 | $3.60 | $5K | 181,594 |
| 2024-04-05 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −44,300 | $10.75 | $476K | 187,471 |
| 2024-04-04 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −14,583 | $10.89 | $159K | 261,471 |
| 2024-04-04 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −29,700 | $10.89 | $324K | 231,771 |
| 2024-04-03 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −14,584 | $10.78 | $157K | 302,054 |
| 2024-04-03 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −26,000 | $10.78 | $280K | 276,054 |
| 2024-04-01 | Andrade Robert CHIEF FINANCIAL OFFICER | Purchase | +12,500 | 104,271 | ||
| 2024-04-01 | Raykov Rosty CHIEF EXECUTIVE OFFICER | Purchase | +29,167 | 316,638 | ||
| 2024-03-26 | RALLIS CHRIS A Director | Sale 10b5-1 | −2,114 | $10.97 | $23K | 40,920 |
| 2024-03-26 | RALLIS CHRIS A Director | Option exercise 10b5-1 | +4,329 | $2.31 | $10K | 45,249 |
| 2024-03-26 | RALLIS CHRIS A Director | Option exercise · Common Shares 10b5-1 | −4,329 | $2.31 | $10K | 182,983 |
| 2024-03-26 | Andrade Robert CHIEF FINANCIAL OFFICER | Sale | −13,975 | $10.90 | $152K | 91,771 |
Page 15 of 17 · 340 trades